Non-Invasive Blood Test Cross-Validation Study

Sponsor
Joseph Allen Jr. (Industry)
Overall Status
Completed
CT.gov ID
NCT03991637
Collaborator
University of North Dakota (Other)
90
1
2
7.4
12.1

Study Details

Study Description

Brief Summary

The study considers a cross-validation approach to determine the effectiveness of a non-invasive comprehensive metabolic panel (NICMP), relative to the venipuncture method. The NICMP machine learned powered device utilizes a light sensor to capture readings from either palm. The study (n=90) proves an agreement and strong correlation with respect to the NICMP and venipuncture blood draw.

Condition or Disease Intervention/Treatment Phase
  • Device: Non-Invasive Comprehensive Metabolic Panel
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Remote Sensing Comprehensive Metabolic Panel
Actual Study Start Date :
Jul 18, 2018
Actual Primary Completion Date :
Sep 11, 2018
Actual Study Completion Date :
Mar 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: NICMP Spectral Reading

Non-invasive spectral data is collected from this arm to function as the intervention of interest.

Device: Non-Invasive Comprehensive Metabolic Panel
The device utilizes spectroscopy and machine learning to detect metabolic analyte concentrations.

Active Comparator: Venipuncture CMP

A standard CMP blood draw is performed to function as the "gold standard" reference value. Specifically, the outcome of the experimental arm is cross-validated against the active comparator arm to determine the NICMP accuracy, relative to the venipuncture method.

Device: Non-Invasive Comprehensive Metabolic Panel
The device utilizes spectroscopy and machine learning to detect metabolic analyte concentrations.

Outcome Measures

Primary Outcome Measures

  1. Performance of Non-Invasive Comprehensive Metabolic Panel [2-minutes]

    Determine the effectiveness, in terms of accuracy, of the NICMP against the venipuncture CMP (i.e. reference value).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Undiagnosed population
Exclusion Criteria:
  • Diagnosed population, pregnant women, mental heath/disabled, prisoners, fetus or deceased

Contacts and Locations

Locations

Site City State Country Postal Code
1 Altru Health System Grand Forks North Dakota United States 58201

Sponsors and Collaborators

  • Joseph Allen Jr.
  • University of North Dakota

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Joseph Allen Jr., Chief Executive Officer/Biomedical Engineer, Concord Medical Technology Corporation
ClinicalTrials.gov Identifier:
NCT03991637
Other Study ID Numbers:
  • IRB-201807-004
First Posted:
Jun 19, 2019
Last Update Posted:
Jun 24, 2019
Last Verified:
Jun 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes

Study Results

No Results Posted as of Jun 24, 2019